Comparison of transplant listing strategy in two renal dialysis centres within a regional transplant alliance
Publication date
2005-12Keyword
Transplant listing strategyRenal dialysis centres
Regional transplant alliance
Transplant organs
Peer-Reviewed
NoOpen Access status
closedAccess
Metadata
Show full item recordAbstract
Aims: An increasing dialysis population and insufficient supply of transplant organs necessitate that patients are carefully evaluated prior to registration on the national waiting list to ensure effective utilization of a scarce resource. We have assessed listing practice in two renal units within the North of England Transplant Alliance. Methods: Demographic, ethnic and clinical data were recorded at initiation of dialysis for patients from two northern English cities, Bradford (n = 209) and Hull (n = 202) between 1994 ¿ 2000. Patients were stratified by two co-morbidity scoring systems. Multivariate and survival analyses were undertaken by registration status. Results: Overall, 159 patients were registered onto the waiting list. Stratification by co-morbidity predicted listing at high and low risk, but with overlap at medium scores. There was no difference in overall co-morbid burden between the two centers (p = 0.161 and 0.316, respectively, for two scoring systems). Logistic regression analysis demonstrated a center effect, Hull having an odds ratio for listing of 0.48 compared to Bradford (p = 0.041). Short- and medium-term survival in the listed group was high regardless of co-morbid score (22 vs 174 deaths in the non-listed group). In this cohort, five patients died with grafts, another three died whilst active on the waiting list. The remaining 14 patients had been removed from the list prior to death. Summary: Co-morbidity scoring schemes are unlikely to be sophisticated enough to accurately identify those who would most benefit from transplantation, and the value of clinical judgment is well-shown in this study. Standardization of registration will result in more equitable allocation of organs. However, this study has demonstrated that there are differences in listing practices even within a single alliance. Continuous assessment will allow judicious removal from the waiting list of patients who have developed an unacceptable co-morbid burden.Version
No full-text in the repositoryCitation
Jeffrey RF, Akbani H, Scally AJ et al (2005) Comparison of transplant listing strategy in two renal dialysis centres within a regional transplant alliance. Clinical Nephrology. 64(6): 438-443.Link to Version of Record
https://doi.org/10.5414/cnp64438Type
Articleae974a485f413a2113503eed53cd6c53
https://doi.org/10.5414/cnp64438
Scopus Count
Collections
Related items
Showing items related by title, author, creator and subject.
-
Towards Refinement for Measuring Subcutaneously Transplanted Tumour Models in MiceShnyder, Steven; Connah, David; Ugail, Hassan; Hussain, Nosheen (University of BradfordInstitute of Cancer Therapeutics. School of Pharmacy and Medical Sciences. Faculty of Life Sciences, 2021)Evaluation using mouse subcutaneous tumour models is a key process in cancer drug development. Tumour material is implanted subcutaneously and tumour growth measured using callipers. However this methodology can have poor reproducibility and accuracy due to observer variation. Furthermore the physical pressure of using callipers can distress the mouse and lead to tumour damage. Non-invasive digital tumour imaging would reduce handling stresses and allow volume determination without physical contact. This thesis focusses on capturing 2D digital images of subcutaneous tumours, then using image processing and machine learning methods to determine 3D volume. The biggest challenge faced was lack of differentiation between tumour and surrounding skin, rendering tumour boundary identification difficult. Whilst image processing methods such as colour segmentation and edge detection were unsuccessful, machine learning proved more successful. Three convolutional neural networks, VGG-Face, VGG-19 and VGG-16 models were evaluated, with VGG-Face producing the best results. Using the layer FC7 before RELU activation for extraction in the VGC-Face model, a tumour recognition rate of 98.86% was achieved. This was increased to 100% through a semi-automatic step with detection repeated on cropped versions of negatively classified images. Finally, volume was determined through extracting image features using the VGG-Face model and conducting partial least squares regression (error of 0.1). This work has successfully demonstrated that with computational methods the volume of subcutaneous tumours can be evaluated through non-invasive digital imaging without need to have contact with the tumour itself, thus offering refinement benefits to the mice as well as eliminating observer bias.
-
Transplantation of Human Chorion-Derived Cholinergic Progenitor Cells: a Novel Treatment for Neurological DisordersMohammadi, A.; Maleki-Jamshid, A.; Sanooghi, D.; Milan, P.B.; Rahmani, A.; Sefat, Farshid; Shahpasand, K.; Soleimani, Morteza; Bakhtiari, M.; Belali, R.; et al. (2018-01)A neurological disorder is any disorder or abnormality in the nervous system. Among different neurological disorders, Alzheimer’s disease (AD) is recognized as the sixth leading cause of death globally. Considerable research has been conducted to find pioneer treatments for this devastating disorder among which cell therapy has attracted remarkable attentions over the last decade. Up to now, targeted differentiation into specific desirable cell types has remained a major obstacle to clinical application of cell therapy. Also, potential risks including uncontrolled growth of stem cells could be disastrous. In our novel protocol, we used basal forebrain cholinergic progenitor cells (BFCN) derived from human chorion-derived mesenchymal stem cells (hC-MSCs) which made it possible to obtain high-quality population of cholinergic neurons and in vivo in much shorter time period than previous established methods. Remarkably, the transplanted progenitors fully differentiated to cholinergic neurons which in turn integrated in higher cortical networks of host brains, resulting in significant improvement in cognitive assessments. This method may have profound implications in cell therapies for any other neurodegenerative disorders.
-
Anti-vascular effects of vinflunine in the MAC 15A transplantable adenocarcinoma modelBibby, Michael C.; Hill, B.T.; Holwell, S.E. (2001)Anti-vascular effects of the novel Vinca alkaloid, vinflunine have been investigated in the MAC 15A transplantable murine colon adenocarcinoma model and compared with those induced by the most recently identified clinically useful third generation Vinca. Administration of the maximum tolerated dose of either vinflunine (50 mg kg-1) or vinorelbine (8 mg kg-1) resulted in significant tumour growth delay with subsequent histological analysis revealing substantial haemorrhagic necrosis. This suggested possible anti-vascular effects and these were confirmed by Hoechst 33342 perfusion studies. Vinflunine, currently undergoing Phase I trials in Europe, was found to be at least as effective as the clinically active vincristine and vinorelbine in this model and, remarkably, produced anti-vascular effects at doses much lower than the maximum tolerated dose. Although vinflunine caused apoptosis in HUVEC monolayer cultures this event did not occur within the first 8 hours of exposure whereas vascular shutdown in vivo was observed within the first 4 hours.